YahooOctober 26, 2026 at 3:13 AM NYYesterday
Johnson & Johnson Prostate Cancer Drug Shrinks Tumors In Early Stage Trial
Key Stats for Johnson & Johnson StockPrice change for Johnson & Johnsonstock in the last 6 months: 16%$JNJ Stock Price as of Oct. 23: $26452-Week High: $281$JNJ Stock Price Target: $279__Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free)__>>> What Happened?Johnson & Johnson (JNJ:NYSE) said its experimental prostate cancer pill caused tumors to shrink or disappear in an early-stage trial.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
